Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP vs BEP in Intermediate- and Poor-Risk Germ Cell Tumors
NCT01873326Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2013
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, ifosfamide in germ cell tumor (GCT), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2013; status: active, not recruiting.
02
Drugs
Paclitaxel Micelles for Injectionifosfamide
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT01873326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01873326.